No Data
No Data
Strategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges
Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement
Express News | Genevant: Seeking Monetary Relief, Injunctions Against Spikevax &, Where Applicable, Additional Products That Moderna Represented Use Same Lnp Tech
Express News | Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Positive Outlook on Arbutus Biopharma Amid Strategic Focus and Legal Developments
$ABUS Stock Is up 7% Today. Here's What We See in Our Data.